Freenome

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.

Linus Health is a next-generation digital cognitive assessment platform that enables earlier detection and intervention in brain health. It brings the power of AI to long-trusted cognitive tests, delivering rich insights and actionable clinical guidance. Linus Health's technology has been validated in over 20 published studies and is used by leading organizations to transform their approach to brain health.

Viz.ai is an AI-powered care coordination platform that helps providers improve patient outcomes. The platform uses advanced algorithms to analyze medical imaging data and provide real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions are used by hospitals and health systems across the country to improve care for patients with a variety of conditions, including stroke, heart disease, and cancer.

Lunit Inc. is a leading provider of AI-powered cancer screening and treatment solutions. The company's mission is to conquer cancer through AI by developing innovative technologies that can help detect and treat cancer earlier and more effectively. Lunit's AI solutions are used by hospitals and clinics around the world to improve the accuracy and efficiency of cancer diagnosis and treatment.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

Viz.ai is a leading provider of AI-powered care coordination solutions for healthcare providers. Its comprehensive platform leverages advanced algorithms to analyze medical imaging data, providing real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions cover a wide range of therapeutic areas, including neurology, cardiology, vascular medicine, trauma, and radiology. The company's mission is to improve patient outcomes by closing the gaps between patients, clinicians, and life-saving treatments.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Proscia is a leading provider of digital pathology solutions for the modern laboratory. Its flagship product, Concentriq, is an enterprise pathology platform that enables anatomic pathology laboratories to achieve 100% digitization and deliver faster, more precise results. Proscia also offers a range of AI applications that can be used to automate tasks, improve diagnostic accuracy, and accelerate research. The company's mission is to perfect cancer diagnosis with intelligent software that changes the way the world practices pathology.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. Our clinically-proven, AI-based digital care platform works with coronary computed tomography angiography (CCTA) imaging to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis - plaque build-up in the heart's arteries - not indirect markers such as risk factors and symptoms of disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease evaluation and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes.

Butterfly iQ3 is a handheld, whole-body ultrasound device that provides clear and detailed images for a variety of medical applications. It is the third-generation probe from Butterfly Network, and it features double the processing power and clearer images than its predecessors. Butterfly iQ3 is also equipped with real-time AI, which can help clinicians to identify and diagnose medical conditions more quickly and accurately. The device is lightweight and portable, making it easy to use in a variety of settings, including the clinic, the hospital, and the field. Butterfly iQ3 is a valuable tool for clinicians who want to improve the quality of care they provide to their patients.

Limbic is a clinical AI application designed for mental healthcare providers to save time, improve outcomes, and maximize impact. It offers a suite of tools developed by a team of therapists, physicians, and PhDs in computational psychiatry. Limbic is known for its evidence-based approach, safety focus, and commitment to patient care. The application leverages AI technology to enhance various aspects of the mental health pathway, from assessments to therapeutic content delivery. With a strong emphasis on patient safety and clinical accuracy, Limbic aims to support clinicians in meeting the rising demand for mental health services while improving patient outcomes and preventing burnout.

Regard is an AI-powered healthcare solution that automates clinical tasks, making it easier for clinicians to focus on patient care. It integrates with the EHR to analyze patient records and provide insights that can help improve diagnosis and treatment. Regard has been shown to improve hospital finances, patient safety, and physician happiness.

Ignota Labs is a technology company focused on rescuing failing drugs and bringing new life to abandoned projects, ultimately providing hope to patients. The company utilizes a proprietary AI model, SAFEPATH, which applies deep learning to bioinformatics and cheminformatics datasets to solve drug safety issues. Ignota Labs aims to identify promising drug targets, address safety problems in clinical trials, and accelerate the delivery of therapeutically effective drugs to patients.

Oatmeal Health is an AI-enabled cancer screening and clinical trials platform designed to support Community Health Centers and improve patient outcomes. By seamlessly integrating AI technology with dedicated virtual care teams, Oatmeal Health facilitates evidence-based cancer screenings, care navigation, and diagnostic screenings to enhance value-based revenue and quality metrics. The platform aims to prevent late-stage cancer by providing early diagnosis and personalized risk assessments, ultimately saving lives and reducing the overall cost of cancer care.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Galleri is a multi-cancer early detection test that uses a single blood draw to screen for over 50 types of cancer. It is recommended for adults aged 50 or older who are at an elevated risk for cancer. Galleri is not a diagnostic test and does not detect all cancers. A positive result requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

iCAD is an AI-powered application designed for cancer detection, specifically focusing on breast cancer. The platform offers a suite of solutions including Detection, Density Assessment, and Risk Evaluation, all backed by science, clinical evidence, and proven patient outcomes. iCAD's AI-powered solutions aim to expose the hiding place of cancer, providing certainty and peace of mind, ultimately improving patient outcomes and saving more lives.

The Unlearn Platform is an AI-powered platform that streamlines clinical trials by creating digital twins of patients using clinical trial data. It predicts clinical outcomes with unparalleled precision, accelerates timelines, enhances decision-making, and identifies sensitive clinical outcomes. The platform minimizes trial failure, cuts costs, and accelerates approval, ultimately optimizing study endpoints and composite scores.

DrugCard is an AI-enabled Data Intelligence platform designed to streamline drug safety routines by providing continuous and regular, traceable, transparent, accurate, complete, and scalable solutions for pharmacovigilance processes. The platform supports over 100 languages, monitors 1000+ local journals, and saves up to 70% of time compared to manual approaches. DrugCard caters to CROs, MAHs, and freelancers, offering efficient local literature screening services to ensure compliance with regulatory requirements and enhance productivity.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Insight is an AI-powered medical research tool that serves as a research assistant for generating scientific summaries, hypotheses, experimental designs, and target identification. It empowers scientists to navigate literature, formulate hypotheses, and design experiments by utilizing peer-reviewed databases to provide reliable outputs. With integrated features like NIH PubMed access, NIH Reporter insights, and MYGENE & MYVARIANT deep dives, Insight streamlines the research process and accelerates discoveries in the medical field.

Biofourmis is a healthcare technology company that provides a connected technology platform for care delivery and drug development. The platform enables healthcare systems and pharmaceutical companies to deliver care and conduct clinical trials remotely, and to collect and analyze data to improve patient outcomes. Biofourmis's solutions have been shown to improve clinical, operational, and economic outcomes, such as reducing 30-day readmissions by 70%, detecting deterioration 21 hours sooner, and reducing cost of care by up to 38%.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

CompliantChatGPT is a HIPAA-compliant platform that allows users to utilize OpenAI's GPT models for healthcare-related tasks while maintaining data privacy and security. It anonymizes protected health information (PHI) by replacing it with tokens, ensuring compliance with HIPAA regulations. The platform offers various modes tailored to specific healthcare needs, including bloodwork analysis, PHI anonymization, diagnosis assistance, and treatment planning. CompliantChatGPT streamlines healthcare tasks, enhances productivity, and provides user-friendly assistance through its intuitive interface.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Nucleai is an AI-driven spatial biomarker analysis tool that leverages military intelligence-grade geospatial AI methods to analyze complex cellular interactions in a patient's biopsy. The platform offers a first-of-its-kind multimodal solution by ingesting images from various modalities and delivering actionable insights to optimize biomarker scoring, predict response to therapy, and revolutionize disease diagnosis and treatment.

Mendel AI is an advanced clinical AI tool that deciphers clinical data with clinician-like logic. It offers a fully integrated suite of clinical-specific data processing products, combining OCR, de-identification, and clinical reasoning to interpret medical records. Users can ask questions in plain English and receive accurate answers from health records in seconds. Mendel's technology goes beyond traditional AI by understanding patient-level data and ensuring consistency and explainability of results in healthcare.

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

Ignota Labs is a technology company focused on rescuing failing drugs and bringing new life to abandoned projects, ultimately providing hope to patients. The company utilizes a proprietary AI model, SAFEPATH, which applies deep learning to bioinformatics and cheminformatics datasets to solve drug safety issues. Ignota Labs aims to identify promising drug targets, address safety problems in clinical trials, and accelerate the delivery of therapeutically effective drugs to patients.

Rationale is a cutting-edge decision-making AI tool that leverages the power of the latest GPT technology and in-context learning. It is designed to assist users in making informed decisions by providing valuable insights and recommendations based on data analysis and machine learning algorithms. With its advanced capabilities, Rationale aims to streamline decision-making processes and enhance overall efficiency in various domains.

Formula Wizard is an AI-powered software designed to assist users in writing Excel, Airtable, and Notion formulas effortlessly. By leveraging artificial intelligence, the application automates the process of formula creation, allowing users to save time and focus on more critical tasks. With features like automating tedious tasks, unlocking insights from data, and customizing templates, Formula Wizard streamlines the formula-writing process for various spreadsheet applications.

PAY77 is an online platform offering a variety of games and products for users to enjoy and purchase. Users can access a wide range of electronic devices, fashion items, beauty products, and more through the platform. Additionally, PAY77 provides a convenient and trusted platform for users to participate in online games and place bets. The platform also offers a selection of popular online games with cash prizes, making it an attractive choice for gaming enthusiasts.

Lintas88 is a trusted and best online Toto and Togel site #1 in the world of online gambling. It offers various interesting and profitable online Togel games, known for its transparent, accessible, and secure gaming system. With years of experience in the online gambling industry, Lintas88 has built a reputation as a trusted Toto site that players worldwide can rely on.

Luminal is a powerful AI copilot that enables users to clean, transform, and analyze spreadsheets 10x faster. It offers fast and efficient data analysis capabilities, allowing users to perform complex operations, answer sophisticated questions, and run AI-enabled tasks using natural language. Luminal simplifies data processing, visualization, and editing, making it a valuable tool for professionals and individuals alike. The application supports multiple languages, ensures secure data hosting with encryption, and offers flexible pricing plans to cater to varying needs.

75 Wbet Com Daftar : OLX500 is an online platform offering a variety of casino games, including slots, live casino, poker, and more. Users can access popular games like Sweet Bonanza, Mahjong Ways, and Gates of Olympus. The platform also provides guidance on how to install the app on Android devices. With a focus on responsible gambling, 75 Wbet Com Daftar : OLX500 aims to enhance the gaming experience for its users.

The website is currently displaying a 'Not Found' message, indicating that the page or content being accessed is unavailable. It seems that the requested information is missing or the URL is incorrect. The website may be experiencing technical issues or the content has been removed. Please check the URL and try again later.

Emotion Logic Ltd is an AI application that specializes in genuine emotion detection from voice data. The technology provides valuable insights across various sectors, including fraud investigations, healthcare, education, and customer service. Emotion Logic's advanced voice analysis capabilities help users accurately decipher unspoken emotions, enhancing user experiences and gaining valuable insights.

functime is a time-series machine learning tool designed for scalable analysis. It offers a comprehensive set of functions for forecasting, evaluation, and analysis of time-series data. With features like scoring, ranking, and plotting functions, functime simplifies the process of evaluating thousands of forecasts simultaneously. It serves as an AI copilot to help analysts analyze and compare trends, seasonality, and causal factors in forecasts. The tool also provides detailed API reference for seamless integration into existing workflows.

Knowledgio is a no-code solution for building personalized AI tools, designed to save time and transform expertise into unique AI applications. Users can easily create their AI workspace, embed knowledge, share, and monetize their AI tools. The platform offers an easy-to-use interface, dedicated support, and automated distribution features to help users build and publish AI tools in minutes.